Researchers have discovered that an overlooked type of immune cell, called gamma delta T cells, can effectively strip away the disguise of aggressive small cell lung cancer to kill the tumor cells in lab tests, a process that becomes even more potent when paired with existing drugs.
Small cell lung cancer (SCLC) is a particularly aggressive and deadly disease: fewer than 7 in 100 people survive it for five years.